{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:50:56Z","timestamp":1791258656753,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05963-w","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:03:57Z","timestamp":1791255837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triptolide as a multi-target anticancer agent: molecular mechanisms and translational potential"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1587-2838","authenticated-orcid":false,"given":"Md.","family":"Shadin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Shakil Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagor","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachurjo Kumar","family":"Swadesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikram","family":"Sana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Ripon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehedi Hasan","family":"Linkon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Adam","family":"Shafiulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muftarin Zaman","family":"Aivy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Shourov","family":"Hossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Torequl","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"4","key":"5963_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/biof.1944","volume":"49","author":"AH AbdulHussein","year":"2023","unstructured":"AbdulHussein AH, Al\u2010Taee MM, Radih ZA, Aljuboory DS, Mohammed ZQ, Hashesh TS, Riadi Y, Hadrawi SK, Najafi M (2023) Mechanisms of cancer cell death induction by triptolide. BioFactors 49(4):718\u2013735","journal-title":"BioFactors"},{"issue":"1","key":"5963_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12935-024-03336-y","volume":"24","author":"S Bao","year":"2024","unstructured":"Bao S, Yi M, Xiang B, Chen P (2024) Antitumor mechanisms and future clinical applications of the natural product triptolide. Cancer Cell Int 24(1):150","journal-title":"Cancer Cell Int"},{"issue":"2","key":"5963_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/oncolo\/oyad278","volume":"29","author":"E Borazanci","year":"2024","unstructured":"Borazanci E, Saluja A, Gockerman J, Velagapudi M, Korn R, Von Hoff D, Greeno E (2024) First-in-human phase I study of minnelide in patients with advanced gastrointestinal cancers: safety, pharmacokinetics, pharmacodynamics, and antitumor activity. Oncologist 29(2):132\u2013141","journal-title":"Oncologist"},{"issue":"6","key":"5963_CR4","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5963_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030550","volume":"16","author":"W Chang","year":"2024","unstructured":"Chang W, Wang J, You Y, Wang H, Xu S, Vulcano S, Xu C, Shen C, Li Z, Wang J (2024) Triptolide reduces neoplastic progression in hepatocellular carcinoma by downregulating the lipid lipase signaling pathway. Cancers (Basel) 16(3):550","journal-title":"Cancers (Basel)"},{"key":"5963_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216622","volume":"587","author":"P Chen","year":"2024","unstructured":"Chen P, Zhong X, Song Y, Zhong W, Wang S, Wang J, Huang P, Niu Y, Yang W, Ding Z (2024) Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells. Cancer Lett 587:216622","journal-title":"Cancer Lett"},{"key":"5963_CR7","doi-asserted-by":"publisher","unstructured":"Cheng X, Shi W, Zhao C, Zhang D, Liang P, Wang G, Lu L (2016) Triptolide sensitizes human breast cancer cells to tumor necrosis factor-\u03b1-induced apoptosis by inhibiting activation of the nuclear factor-\u03baB pathway. Mol Med Rep 13(4):3257\u20133264. https:\/\/doi.org\/10.3892\/mmr.2016.4931","DOI":"10.3892\/mmr.2016.4931"},{"key":"5963_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01614","volume":"10","author":"AS Choudhari","year":"2020","unstructured":"Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O (2020) Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front Pharmacol 10:1614","journal-title":"Front Pharmacol"},{"issue":"1","key":"5963_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12935-022-02624-9","volume":"22","author":"P Dhyani","year":"2022","unstructured":"Dhyani P, Quispe C, Sharma E, Bahukhandi A, Sati P, Attri DC, Szopa A, Sharifi-Rad J, Docea AO, Mardare I (2022) Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine. Cancer Cell Int 22(1):206","journal-title":"Cancer Cell Int"},{"issue":"1","key":"5963_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12964-024-01607-9","volume":"22","author":"A Doostmohammadi","year":"2024","unstructured":"Doostmohammadi A, Jooya H, Ghorbanian K, Gohari S, Dadashpour M (2024) Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents. Cell Commun Signal 22(1):228","journal-title":"Cell Commun Signal"},{"key":"5963_CR11","doi-asserted-by":"publisher","unstructured":"Gao H, Zhang Y, Dong L, Qu X-Y, Tao L-N, Zhang Y-M, Zhai J-H, Song Y-Q (2018) Triptolide induces autophagy and apoptosis through ERK activation in human breast cancer MCF-7 cells. Exp Ther Med 15(4):3413\u20133419. https:\/\/doi.org\/10.3892\/etm.2018.5830","DOI":"10.3892\/etm.2018.5830"},{"issue":"15","key":"5963_CR12","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.7150\/thno.57745","volume":"11","author":"J Gao","year":"2021","unstructured":"Gao J, Zhang Y, Liu X, Wu X, Huang L, Gao W (2021) Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives. Theranostics 11(15):7199","journal-title":"Theranostics"},{"key":"5963_CR13","doi-asserted-by":"publisher","unstructured":"Hamdi AM, Jiang ZZ, Guerram M, Yousef BA, Hassan HM, Ling JW, Zhang LY (2018) Biochemical and computational evaluation of triptolide-induced cytotoxicity against NSCLC. Biomed Pharmacother 103:1557\u20131566. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.198","DOI":"10.1016\/j.biopha.2018.04.198"},{"issue":"1","key":"5963_CR14","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3892\/ol.2021.12823","volume":"22","author":"O-Y Hong","year":"2021","unstructured":"Hong O-Y, Jang H-Y, Park K-H, Jeong Y-J, Kim J-S, Chae HS (2021) Triptolide inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cells through the inhibition of NF-\u03baB and AP-1 signaling pathways. Oncol Lett 22(1):562","journal-title":"Oncol Lett"},{"key":"5963_CR15","doi-asserted-by":"publisher","unstructured":"Hu H, Luo L, Liu F, Zou D, Zhu S, Tan B, Chen T (2016) Anti-cancer and sensibilisation effect of triptolide on human epithelial ovarian cancer. J Cancer 7(14):2093\u20132099. https:\/\/doi.org\/10.7150\/jca.16178","DOI":"10.7150\/jca.16178"},{"issue":"13","key":"5963_CR16","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.7150\/jca.30669","volume":"10","author":"G Huang","year":"2019","unstructured":"Huang G, Hu H, Zhang Y, Zhu Y, Liu J, Tan B, Chen T (2019a) Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT. J Cancer 10(13):3012","journal-title":"J Cancer"},{"key":"5963_CR17","doi-asserted-by":"publisher","unstructured":"Huang Y, Chen Z, Wang Y, Ba X, Huang Y, Shen P, Wang H, Tu S (2019) Triptolide exerts an anti-tumor effect on non-small cell lung cancer cells by inhibiting activation of the IL-6\/STAT3 axis. Int J Mol Med 44(1):291\u2013300.\u00a0https:\/\/doi.org\/10.3892\/ijmm.2019.4197","DOI":"10.3892\/ijmm.2019.4197"},{"key":"5963_CR18","doi-asserted-by":"publisher","unstructured":"Jacobson BA, Chen EZ, Tang S, Belgum HS, McCauley JA, Evenson KA, Etchison RG, Jay-Dixon J, Patel MR, Raza A, Saluja AK, D'Cunha J, Kratzke RA (2015) Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma. Genes Cancer\u00a06(3\u20134):144\u2013152. https:\/\/doi.org\/10.18632\/genesandcancer.55","DOI":"10.18632\/genesandcancer.55"},{"key":"5963_CR19","doi-asserted-by":"publisher","unstructured":"Jiang W, Chen M, Xiao C, Yang W, Qin Q, Tan Q, Liang Z, Liao X, Mao A, Wei C (2019) Triptolide suppresses growth of breast cancer by targeting HMGB1 in vitro and in vivo. Biol Pharm Bull 42(6):892\u2013899. https:\/\/doi.org\/10.1248\/bpb.b18-00818","DOI":"10.1248\/bpb.b18-00818"},{"issue":"5","key":"5963_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051100","volume":"14","author":"S Kamran","year":"2022","unstructured":"Kamran S, Sinniah A, Abdulghani MA, Alshawsh MA (2022) Therapeutic potential of certain terpenoids as anticancer agents: a scoping review. Cancers (Basel) 14(5):1100","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5963_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0698-2","volume":"37","author":"S-G Li","year":"2018","unstructured":"Li S-G, Shi Q-W, Yuan L-y, Qin L-p, Wang Y, Miao Y-Q, Chen Z, Ling C-Q, Qin W-x (2018a) C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells. J Exp Clin Cancer Res 37(1):51","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"5963_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbrc.2018.01.052","volume":"496","author":"X Li","year":"2018","unstructured":"Li X, Lu Q, Xie W, Wang Y, Wang G (2018b) Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt\/\u03b2-Catenin signaling. Biochem Biophys Res Commun 496(2):443\u2013449","journal-title":"Biochem Biophys Res Commun"},{"key":"5963_CR23","doi-asserted-by":"publisher","unstructured":"Li F, Cui H, Jin X, Gong X, Wang W, Wang J (2020) Triptolide inhibits epithelial-mesenchymal transition and induces apoptosis in gefitinib-resistant lung cancer cells. Oncol Rep 43(5):1569\u20131579. https:\/\/doi.org\/10.3892\/or.2020.7542","DOI":"10.3892\/or.2020.7542"},{"issue":"1","key":"5963_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41419-024-06446-7","volume":"15","author":"M Li","year":"2024","unstructured":"Li M, Yu J, Ju L, Wang Y, Jin W, Zhang R, Xiang W, Ji M, Du W, Wang G, Qian K, Zhang Y, Xiao Y, Wang X (2024) USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer. Cell Death Dis 15(1):44. https:\/\/doi.org\/10.1038\/s41419-024-06446-7","journal-title":"Cell Death Dis"},{"issue":"1","key":"5963_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13046-019-1232-x","volume":"38","author":"X Liang","year":"2019","unstructured":"Liang X, Xie R, Su J, Ye B, Wei S, Liang Z, Bai R, Chen Z, Li Z, Gao X (2019) Inhibition of RNA polymerase III transcription by triptolide attenuates colorectal tumorigenesis. J Exp Clin Cancer Res 38(1):217. https:\/\/doi.org\/10.1186\/s13046-019-1232-x","journal-title":"J Exp Clin Cancer Res"},{"key":"5963_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fonc.2019.00387","volume":"9","author":"X Liu","year":"2019","unstructured":"Liu X, Zhao P, Wang X, Wang L, Zhu Y, Gao W (2019) Triptolide induces glioma cell autophagy and apoptosis via upregulating the ROS\/JNK and downregulating the Akt\/mTOR signaling pathways. Front Oncol 9:387","journal-title":"Front Oncol"},{"issue":"3","key":"5963_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13439","volume":"31","author":"K Liu","year":"2025","unstructured":"Liu K, Liu J, Meng T, Wu N, Liu J, Qiao M, Dong L, Liu J (2025a) Triptolide reverses cis\u2011diamminedichloroplatinum resistance in esophageal squamous cell carcinoma by suppressing glycolysis and causing mitochondrial malfunction. Mol Med Rep 31(3):74","journal-title":"Mol Med Rep"},{"key":"5963_CR28","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13439","author":"K Liu","year":"2025","unstructured":"Liu K, Liu J, Meng T, Wu N, Liu J, Qiao M, Dong L, Liu J (2025) Triptolide reverses cis\u2011diamminedichloroplatinum resistance in esophageal squamous cell carcinoma by suppressing glycolysis and causing mitochondrial malfunction. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2025.13439","journal-title":"Mol Med Rep"},{"issue":"3","key":"5963_CR29","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.3892\/mmr.2018.9263","volume":"18","author":"X Mao","year":"2018","unstructured":"Mao X, Tong J, Wang Y, Zhu Z, Yin Y, Wang Y (2018) Triptolide exhibits antitumor effects by reversing hypermethylation of WIF-1 in lung cancer cells. Mol Med Rep 18(3):3041\u20133049. https:\/\/doi.org\/10.3892\/mmr.2018.9263","journal-title":"Mol Med Rep"},{"key":"5963_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1049888","volume":"12","author":"Y Nan","year":"2023","unstructured":"Nan Y, Su H, Zhou B, Liu S (2023) The function of natural compounds in important anticancer mechanisms. Front Oncol 12:1049888","journal-title":"Front Oncol"},{"issue":"10","key":"5963_CR31","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1002\/ijc.31756","volume":"143","author":"I Nardi","year":"2018","unstructured":"Nardi I, Reno T, Yun X, Sztain T, Wang J, Dai H, Zheng L, Shen B, Kim J, Raz D (2018) Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3. Int J Cancer 143(10):2470\u20132478. https:\/\/doi.org\/10.1002\/ijc.31756","journal-title":"Int J Cancer"},{"issue":"7","key":"5963_CR32","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","volume":"9","author":"T Nechiporuk","year":"2019","unstructured":"Nechiporuk T, Kurtz SE, Nikolova O, Liu T, Jones CL, D\u2019Alessandro A, Culp-Hill R, d\u2019Almeida A, Joshi SK, Rosenberg M (2019) The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discov 9(7):910\u2013925","journal-title":"Cancer Discov"},{"issue":"5","key":"5963_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","volume":"40","author":"P Noel","year":"2019","unstructured":"Noel P, Von Hoff DD, Saluja AK, Velagapudi M, Borazanci E, Han H (2019) Triptolide and its derivatives as cancer therapies. Trends Pharmacol Sci 40(5):327\u2013341","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"5963_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/labinvest.2015.46","volume":"95","author":"A Oliveira","year":"2015","unstructured":"Oliveira A, Beyer G, Chugh R, Skube SJ, Majumder K, Banerjee S, Sangwan V, Li L, Dawra R, Subramanian S, Saluja A, Dudeja V (2015) Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F. Lab Invest 95(6):648\u2013659. https:\/\/doi.org\/10.1038\/labinvest.2015.46","journal-title":"Lab Invest"},{"issue":"3","key":"5963_CR35","first-page":"3929","volume":"16","author":"G Qin","year":"2018","unstructured":"Qin G, Li P, Xue Z (2018) Triptolide induces protective autophagy and apoptosis in human cervical cancer cells by downregulating Akt\/mTOR activation. Oncol Lett 16(3):3929\u20133934","journal-title":"Oncol Lett"},{"issue":"5","key":"5963_CR36","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.athoracsur.2015.05.074","volume":"100","author":"TA Reno","year":"2015","unstructured":"Reno TA, Kim JY, Raz DJ (2015) Triptolide inhibits lung cancer cell migration, invasion, and metastasis. Ann Thorac Surg 100(5):1817\u20131824. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.05.074","journal-title":"Ann Thorac Surg"},{"key":"5963_CR37","doi-asserted-by":"publisher","unstructured":"Rodriguez-Blanco J, Salvador AD, Suter RK, Swiderska-Syn M, Palomo-Caturla I, Kliebe V, Shahani P, Peterson K, Turos-Cabal M, Vieira ME, Wynn DT, Howell AJ, Yang F, Ban Y, McCrea HJ, Zindy F, Danis E, Vibhakar R, Jermakowicz A, \u2026 Robbins DJ (2024) Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models. J Clin Invest 134(15):e171136. https:\/\/doi.org\/10.1172\/JCI171136","DOI":"10.1172\/JCI171136"},{"issue":"4","key":"5963_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40610-020-00139-8","volume":"6","author":"H Shankar","year":"2020","unstructured":"Shankar H, Saluja S, Rawat M, Singh G, Tarique M, Mohammad N, Naz H (2020) The causal association between occupational, environmental, and lifestyle factors and reproductive cancer risk. Curr Mol Biol Rep 6(4):149\u2013160","journal-title":"Curr Mol Biol Rep"},{"key":"5963_CR39","doi-asserted-by":"publisher","unstructured":"Song JM, Molla K, Anandharaj A, Cornax I, O'Sullivan MG, Kirtane AR, Panyam J, Kassie F (2017) Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44\/RHAMM signaling. Oncotarget 8(16):26927\u201326940. https:\/\/doi.org\/10.18632\/oncotarget.15879","DOI":"10.18632\/oncotarget.15879"},{"issue":"2","key":"5963_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/1389200219666180816141506","volume":"20","author":"W Song","year":"2019","unstructured":"Song W, Liu M, Wu J, Zhai H, Chen Y, Peng Z (2019) Preclinical pharmacokinetics of triptolide: a potential antitumor drug. Curr Drug Metab 20(2):147\u2013154","journal-title":"Curr Drug Metab"},{"key":"5963_CR41","doi-asserted-by":"publisher","unstructured":"Song X, He H, Zhang Y, Fan J, Wang L (2022) Mechanisms of action of triptolide against colorectal cancer: insights from proteomic and phosphoproteomic analyses. Aging 14(7):3084\u20133104. https:\/\/doi.org\/10.18632\/aging.203992","DOI":"10.18632\/aging.203992"},{"issue":"1","key":"5963_CR42","first-page":"E21","volume":"56","author":"I Valle","year":"2015","unstructured":"Valle I, Tramalloni D, Bragazzi N (2015) Cancer prevention: state of the art and future prospects. J Prev Med Hyg 56(1):E21","journal-title":"J Prev Med Hyg"},{"key":"5963_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/biom8040163","author":"E Varghese","year":"2018","unstructured":"Varghese E, Samuel SM, Varghese S, Cheema S, Mamtani R, B\u00fcsselberg D (2018) Triptolide decreases cell proliferation and induces cell death in triple negative MDA-MB-231 breast cancer cells. Biomolecules. https:\/\/doi.org\/10.3390\/biom8040163","journal-title":"Biomolecules"},{"key":"5963_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40364-015-0043-2","volume":"3","author":"G Wang","year":"2015","unstructured":"Wang G, Wang X, Xu X (2015) Triptolide potentiates lung cancer cells to cisplatin-induced apoptosis by selectively inhibiting the NER activity. Biomark Res 3:17. https:\/\/doi.org\/10.1186\/s40364-015-0043-2","journal-title":"Biomark Res"},{"key":"5963_CR45","doi-asserted-by":"publisher","unstructured":"Wang H, Ma D, Wang C, Zhao S, Liu C (2016) Triptolide inhibits invasion and tumorigenesis of hepatocellular carcinoma MHCC-97H cells through NF-\u03baB signaling. Med Sci Monit 22:1827\u20131836. https:\/\/doi.org\/10.12659\/MSM.898801","DOI":"10.12659\/MSM.898801"},{"key":"5963_CR46","doi-asserted-by":"publisher","unstructured":"Wang M, Chen B, Chai L (2019) Triptolide suppresses the proliferation and induces the apoptosis of nasopharyngeal carcinoma cells via the PI3K\/Akt pathway. Oncol Lett 17(1):1372\u20131378. https:\/\/doi.org\/10.3892\/ol.2018.9726","DOI":"10.3892\/ol.2018.9726"},{"key":"5963_CR47","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.2147\/dddt.S322502","volume":"15","author":"F Wang","year":"2021","unstructured":"Wang F, An SJ, Yin Y, Li JJ, Sun CH, Lan J, Zhao WJ, Li CQ (2021) Triptolide is a promising therapeutic approach in treating thyroid cancer based on in silico and in vitro experiment. Drug des Devel Ther 15:4275\u20134287. https:\/\/doi.org\/10.2147\/dddt.S322502","journal-title":"Drug des Devel Ther"},{"issue":"3","key":"5963_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11655-018-2847-z","volume":"25","author":"Y-m Wei","year":"2019","unstructured":"Wei Y-m, Wang Y-h, Xue H-q, Luan Z-h, Liu B-w, Ren J-h (2019) Triptolide, a potential autophagy modulator. Chin J Integr Med 25(3):233\u2013240","journal-title":"Chin J Integr Med"},{"key":"5963_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","volume":"90","author":"C Xi","year":"2017","unstructured":"Xi C, Peng S, Wu Z, Zhou Q, Zhou J (2017) Toxicity of triptolide and the molecular mechanisms involved. Biomed Pharmacother 90:531\u2013541","journal-title":"Biomed Pharmacother"},{"key":"5963_CR50","doi-asserted-by":"publisher","unstructured":"Xie CQ, Zhou P, Zuo J, Li X, Chen Y, Chen JW (2016) Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549\/Taxol cells via modulation of MAPK and PI3K\/Akt signaling pathways. Oncol Lett 12(5):3586\u20133590. https:\/\/doi.org\/10.3892\/ol.2016.5099","DOI":"10.3892\/ol.2016.5099"},{"issue":"17","key":"5963_CR51","doi-asserted-by":"publisher","first-page":"23933","DOI":"10.18632\/oncotarget.8207","volume":"7","author":"J Xiong","year":"2016","unstructured":"Xiong J, Su T, Qu Z, Yang Q, Wang Y, Li J, Zhou S (2016) Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2\/REST pathway in human breast cancer. Oncotarget 7(17):23933\u201323946. https:\/\/doi.org\/10.18632\/oncotarget.8207","journal-title":"Oncotarget"},{"key":"5963_CR52","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejmech.2018.12.058","volume":"164","author":"H Xu","year":"2019","unstructured":"Xu H, Liu B (2019) Triptolide-targeted delivery methods. Eur J Med Chem 164:342\u2013351. https:\/\/doi.org\/10.1016\/j.ejmech.2018.12.058","journal-title":"Eur J Med Chem"},{"key":"5963_CR53","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765202220210938","volume":"94","author":"P Xu","year":"2022","unstructured":"Xu P, Wu Z, Peng Y, Gao J, Zheng F, Tan J, Xu J, Wang T (2022) Neuroprotection of triptolide against Amyloid-Beta 1\u201342-induced toxicity via the Akt\/mTOR\/p70S6K-mediated autophagy pathway. An Acad Bras Cienc 94:e20210938","journal-title":"An Acad Bras Cienc"},{"key":"5963_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2019.02.030","volume":"851","author":"M Yanchun","year":"2019","unstructured":"Yanchun M, Yi W, Lu W, Yu Q, Jian Y, Pengzhou K, Ting Y, Hongyi L, Fang W, Xiaolong C (2019) Triptolide prevents proliferation and migration of esophageal squamous cell cancer via MAPK\/ERK signaling pathway. Eur J Pharmacol 851:43\u201351","journal-title":"Eur J Pharmacol"},{"key":"5963_CR55","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3389\/fphar.2018.00813","volume":"9","author":"L You","year":"2018","unstructured":"You L, Dong X, Ni B, Fu J, Yang C, Yin X, Leng X, Ni J (2018) Triptolide induces apoptosis through fas death and mitochondrial pathways in HepaRG cell line. Front Pharmacol 9:813","journal-title":"Front Pharmacol"},{"issue":"1","key":"5963_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2023.2295785","volume":"58","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lu F (2024) Molecular mechanism of triptolide in myocardial fibrosis through the Wnt\/\u03b2-catenin signaling pathway. Scand Cardiovasc J 58(1):2295785","journal-title":"Scand Cardiovasc J"},{"issue":"12","key":"5963_CR57","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.3390\/ijms17122139","volume":"17","author":"W Zhang","year":"2016","unstructured":"Zhang W, Kang M, Zhang T, Li B, Liao X, Wang R (2016) Triptolide combined with radiotherapy for the treatment of nasopharyngeal carcinoma via NF-\u03baB-related mechanism. Int J Mol Sci 17(12):2139","journal-title":"Int J Mol Sci"},{"key":"5963_CR58","doi-asserted-by":"publisher","unstructured":"Zhang Z, Sun C, Zhang L, Chi X, Ji J, Gao X, Wang Y, Zhao Z, Liu L, Cao X, Yang Y, Mao W (2019) Triptolide interferes with XRCC1\/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin. Biomed Pharmacother 109:1541\u20131546. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.008","DOI":"10.1016\/j.biopha.2018.11.008"},{"issue":"01","key":"5963_CR59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1142\/S0192415X26500072","volume":"54","author":"J Zhang","year":"2026","unstructured":"Zhang J, Huang F, Xu Y, Xie J, Lei Y, Hu Z, Dai Y, Hou X (2026) Molecular mechanisms and therapeutic potentials of triptolide in autoimmune diseases: advances and challenges. Am J Chin Med 54(01):201\u2013228","journal-title":"Am J Chin Med"},{"key":"5963_CR60","doi-asserted-by":"publisher","unstructured":"Zhao X, Zhang Q, Chen L (2016) Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway. Oncol Rep 36(3):1499\u20131505.\u00a0https:\/\/doi.org\/10.3892\/or.2016.4957","DOI":"10.3892\/or.2016.4957"},{"key":"5963_CR61","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S258203","author":"L Zheng","year":"2020","unstructured":"Zheng L, Fang S, Hui J, Rajamanickam V, Chen M, Weng Q, Wu X, Zhao Z, Ji J (2020) Triptonide modulates MAPK signaling pathways and exerts anticancer effects via ER stress-mediated apoptosis induction in human osteosarcoma cells. Cancer Manag Res. https:\/\/doi.org\/10.2147\/CMAR.S258203","journal-title":"Cancer Manag Res"},{"key":"5963_CR62","doi-asserted-by":"publisher","unstructured":"Zheng Y, Kong F, Liu S, Liu X, Pei D, Miao X (2021) Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy. Drug Deliv 28(1):2033\u20132043. https:\/\/doi.org\/10.1080\/10717544.2021.1983072","DOI":"10.1080\/10717544.2021.1983072"},{"key":"5963_CR63","doi-asserted-by":"publisher","unstructured":"Zheng Z, Chen Y, Wang C, Li L, Tan B (2025) Triptolide induces immunogenic cell death in cervical cancer cells via ER stress and redox modulation. Am J Cancer Res 15(1):69\u201383. https:\/\/doi.org\/10.62347\/XNVR3799","DOI":"10.62347\/XNVR3799"},{"issue":"5","key":"5963_CR64","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8020","volume":"45","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Le F, Cheng J, Luo C, Zhang X, Wu X, Xu F, Zuo Q, Tan B (2021a) Triptolide inhibits JAK2\/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin-resistant SKOV3\/DDP ovarian cancer cells. Oncol Rep 45(5):69","journal-title":"Oncol Rep"},{"key":"5963_CR65","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8020","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Le F, Cheng J, Luo C, Zhang X, Wu X, Xu F, Zuo Q, Tan B (2021) Triptolide inhibits JAK2\/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin\u2011resistant SKOV3\/DDP ovarian cancer cells. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2021.8020","journal-title":"Oncol Rep"},{"key":"5963_CR66","doi-asserted-by":"publisher","first-page":"12975","DOI":"10.2147\/ijn.S498099","volume":"19","author":"L Zhou","year":"2024","unstructured":"Zhou L, Du Y, Shang Y, Xiang D, Xia X (2024a) A novel triptolide nano-liposome with mitochondrial targeting for treatment of hepatocellular carcinoma. Int J Nanomedicine 19:12975\u201312998. https:\/\/doi.org\/10.2147\/ijn.S498099","journal-title":"Int J Nanomedicine"},{"key":"5963_CR67","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S498099","author":"L Zhou","year":"2024","unstructured":"Zhou L, Du Y, Shang Y, Xiang D, Xia X (2024b) A novel triptolide nano-liposome with mitochondrial targeting for treatment of hepatocellular carcinoma. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S498099","journal-title":"Int J Nanomedicine"},{"key":"5963_CR68","doi-asserted-by":"publisher","unstructured":"Zhu J, Wang H, Chen F, Lv H, Xu Z, Fu J, Hou Y, Xu Y, Pi J (2018) Triptolide enhances chemotherapeutic efficacy of antitumor drugs in non-small-cell lung cancer cells by inhibiting Nrf2-ARE activity. Toxicol Appl Pharmacol 358:1\u20139.\u00a0https:\/\/doi.org\/10.1016\/j.taap.2018.09.004","DOI":"10.1016\/j.taap.2018.09.004"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05963-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05963-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05963-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:04:02Z","timestamp":1791255842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05963-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":68,"alternative-id":["5963"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05963-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"17 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is a systematic review with narrative synthesis of previously published literature and does not involve human participants or animals; therefore, ethical approval was not required.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}